32D cells expressing v-Ha-Ras fail to show a transformed phenotype. Since Ras requires an active IGF-1R for transformation of ®broblasts, we asked whether expression of IRS-1 or Shc (two of the major substrates of the IGF-1R) could co-operate with oncogenic Ras in transforming 32D cells. We ®nd that IRS-1, but not Shc, in combination with v-Ha-Ras generates a fully transformed phenotype in 32D cells. 32D cells expressing both IRS-1 and v-Ha-Ras (32D/IRS1/Ras) survive and proliferate in the absence of IL-3, do not undergo granulocytic dierentiation in the presence of G-CSF and form tumors in nu/nu and syngeneic mice. In contrast, 32D cells expressing singly IRS-1 or v-HaRas exhibit only a block in dierentiation capacity. Over-expression of Shc proteins, by itself, promotes dierentiation of 32D cells. Concomitant expression of IRS-1 and v-Ha-Ras synergistically phosphorylates ERK-1 and ERK-2 whereas a MEK inhibitor rapidly induces death of 32D/IRS1/Ras transformed cells. Furthermore, transformed 32D/IRS1/Ras cells display high levels of PI3-K activation and undergo rapid apoptosis when exposed to PI3-K inhibitors. The data indicate that: (1) a fully transformed phenotype in 32D cells is generated when a block in dierentiation (v-HaRas) is coupled with another dierentiation block (IRS-1); (2) PI3-K and MAPK activity are required for the survival of transformed cells; (3) the signals generated by IRS-1 and oncogenic Ras converge on ERK and PI3-K resulting in high levels of activation. Oncogene (2000) 19, 3245 ± 3255.
Introduction
Myelodysplastic syndromes show block of dierentiation, but progress to acute leukemia when additional events provide autonomous growth stimulation (Sawyers et al., 1991) . The property of growth factor independence is shared by many growth factor receptor/tyrosine kinase oncogenes. Block of dierentiation is frequently generated by oncogene abnormalities (Ki-Ras, N-Ras) (Bos, 1989) , mutations in p53 tumor suppressor gene (Cheng and Haas, 1990; Kastan et al., 1991; Soddu et al., 1996a) and chromosomal rearrangements such as loss of long arms of chromosomes 5 and 7 (Groopman et al., 1989; Sawyers et al., 1991) . However, the intracellular signaling pathways involved in the phenotypic conversion of myelodysplastic disorders are not yet clari®ed because of the diculties of dissecting the mechanisms by which transformation occurs.
We have approached the problem of pre-leukemic cell transformation by using the 32D-cell line (Greenberger et al., 1983) , a diploid murine hemopoietic cell line with suitable characteristics. 32D cells are strictly interleukin-3 (IL-3)-dependent, and undergo massive apoptosis when IL-3 is withdrawn (Askew et al., 1991; Valtieri et al., 1987) . They dierentiate along the granulocytic lineage when treated with G-CSF (Metcalf, 1985; Valtieri et al., 1987) and do not form tumors in either syngeneic or nu/nu mice (Soddu et al., 1996b) . Moreover, v-Ha-Ras expression generates in 32D cells (32D/Ras) a phenotype similar to myelodysplastic disorders. 32D/Ras cells are still dependent on IL-3 for survival and proliferation and do not form tumors in mice, but exhibit a dierentiation block (Mavilio et al., 1989; Soddu et al., 1996b) .
Previous studies from our laboratories have also established that the type 1 insulin-like growth factor receptor (IGF-1R) plays an important role in the establishment and maintenance of the transformed phenotype (reviewed by Baserga et al., 1997) . In addition, over-expression of IRS-1 (one of the major substrates of the IGF-1R) has been reported to transform cells, provided that they have a detectable level of IGF-1R (D'Ambrosio et al., 1995; Tanaka et al., 1996) . Parental 32D cells express low but detectable levels of IGF-1R, about 2.8610 3 receptors/cell , and are devoid of IRS-1 and IRS-2 (Wang et al., 1993) , which makes them an attractive cell line for studies dealing with the role of IRS-1 in transformation and dierentiation (Wang et al., 1993; Yenush et al., 1996; Zhou-Li et al., 1997) . 32D cells over-expressing the IGF-1R (32D/IGF-1R) are protected from apoptosis upon IL-3 withdrawal (Dews et al., 1998; Zhou-Li et al., 1997) . However, after growing for about 48 h, these cells dierentiate along the granulocytic lineage, even in the absence of G-CSF (Valentinis et al., 1999b) . Stable expression of IRS-1 in 32D/IGF-1R cells inhibits dierentiation and causes these cells to grow inde®nitely in the absence of IL-3 (Valentinis et al., 1999b) . IRS-1, by itself, cannot even protect 32D cells from apoptosis induced by IL-3 withdrawal (Peruzzi et al., 1999) . In contrast, Shc proteins promote dierentiation of 32D cells, as a dominant negative mutant of Shc can inhibit IGF-1-mediated dierentiation (Valentinis et al., 1999b) .
We now asked whether by restoring normal IGF-1R signaling through the expression of IRS-1, or overexpressing the Shc proteins, we might obtain full leukemic conversion of 32D/Ras cells. For this purpose, 32D cells were transduced with IRS-1 or Shc singly or in combination with v-Ha-Ras. The main ®nding is that only the concomitant expression of vHa-Ras and IRS-1 transforms 32D cells: i.e. the cells become IL-3-independent and form tumors in mice. Furthermore, the observation that both v-Ha-Ras and IRS-1, singly, block G-CSF-induced dierentiation of 32D cells raises a second interesting question, i.e. whether v-Ha-Ras and IRS-1 act in an additive way through separate pathways, or simply double the stimulation of a single pathway. Interestingly, we ®nd that transformed cells exhibit constitutive activation of both PI3-K and MAPK and are strictly dependent upon PI3-K and MAPK activity for survival as well as for transformation.
Results

Cell lines and expression of proteins
32D cells do not express either IRS-1 or IRS-2 (Wang et al., 1993; Valentinis et al., 1999b) , express very high levels of the 46 and 52 kDa Shc proteins (Valentinis et al., 1999b) , and do not express the 66 kDa Shc protein (Lanfrancone et al., 1995) . The 32D/IRS1 derived cell line was described previously (Myers et al., 1994) . The 32D/Shc cells were generated by transducing a plasmid expressing the 46 and 52 kDa Shc proteins (the plasmid was a gift of J Schlessinger, New York University, New York, NY, USA). Generation of 32D/Shc cells was very dicult, because parental 32D cells already express high levels of Shc proteins, and because transduced cells have a tendency to dierentiate spontaneously (see below). The 32D/Ras cells were previously described (Soddu et al., 1996b) . The 32D/IRS1/Ras and the 32D/Ras/Shc cells were generated from the 32D/IRS1 and 32D/Shc cells, respectively, employing two retroviruses expressing vHa-Ras (see Materials and methods). Reverse transfectants were also generated in which IRS-1 or Shc expression vectors were introduced into the original 32D/Ras cell line. Since the reverse transfectants behaved similarly to the cell lines listed above, they are omitted for the sake of clarity. Figure 1 shows a Western blot analysis of 32D and 32D-derived cells. The gels were blotted with antibodies anti-Shc (a), anti-IRS-1 (b) or anti-Ras (c). Protein loading was monitored by evaluating hsp-70 kDa expression. Two representative clones (#3 and #10) expressing the Shc plasmid are shown in (a). Quantitative analysis of the bands corresponding to 46 and 52 kDa, indicates that Shc expression increases, albeit modestly, in transfected cells. A 185-kDa protein is recognized in the blot stained with an anti-IRS-1 antibody only in 32D cells transfected with the IRS-1 plasmid. As already mentioned, parental 32D cells are devoid of IRS-1 protein (Wang et al., 1993; Zhou-Li et al., 1997) . Quantitative analysis of the band corresponding to Ras-protein indicates that after infection with replicating v-Ha-Ras expressing retrovirus (32D/Ras cells), there is an increase in the Ras expression over the parental cell population (Figure 1c ), in good agreement with our previous results (Soddu et al., 1996b) . Similar results were obtained when non-replicating (Ras-zip) or replicating (Ha-Ras) retroviruses were employed (Figure 1c) .
Survival and growth of 32D-derived cells 32D/IRS1 and 32D/Shc transfectants were compared with 32D parental cells and 32D/Ras cells ( Figure 2 ). All transfectants proliferate at similar rates in the presence of IL-3 (a). In the absence of IL-3, 32D/ IRS1, 32D/Ras and 32D/Shc cells cannot survive (b). Therefore, neither IRS-1 nor Shc, singly, can abrogate the IL-3 dependence of 32D cells. The inability of vHa-Ras (Mavilio et al., 1989; Soddu et al., 1996b) or IRS-1 (Peruzzi et al., 1999; Zhou-Li et al., 1997) to substitute for IL-3 has been previously reported. 32D cells expressing IRS-1 (32D/IRS1) or Shc (32D/Shc) were then infected with retroviruses carrying v-Ha- Ras. The 32D/IRS1/Ras and 32D/Shc/Ras cells were generated either after infection of 32D/IRS1 or 32D/ Shc cells using v-Ha-Ras retroviral vectors or by transducing IRS-1 and Shc into 32D cells previously infected with dierent v-Ha-Ras retroviral vectors. 32D cells expressing both IRS-1 and v-Ha-Ras were able to grow in the absence of IL-3 and could be generated repeatedly. Proliferation capacity of double transfected cells (32D/IRS1/Ras) in the presence and absence of IL-3 was tested. Figure 2b shows that 32D cells expressing both IRS-1 and v-Ha-Ras are able to grow in the absence of IL-3. In contrast, in spite of several attempts, we were unable to generate stable 32D/Shc/Ras cell populations. In all conditions tested, we always observed rapid death (2 ± 3 days) of double Shc and v-Ha-Ras transfectants, even in the presence of IL-3. Shc proteins are known to activate the Ras pathway (White, 1998) and to promote dierentiation of 32D cells (Valentinis et al., 1999b) . It is therefore not surprising that a combination of Ras and Shc over-expression will result in cell lines with a high tendency to terminal dierentiation (see below) and death.
Differentiation of 32D-derived cells
The ability to dierentiate was investigated by evaluating growth, survival and cell dierentiation in the presence of G-CSF (Figure 3a ,b, respectively). In the presence of G-CSF, 32D parental cells and derivative transfectants (32D/IRS1, 32D/Ras, 32D/ Shc) show low rate of proliferation, accompanied by loss of viability (Figure 3a) . In contrast, proliferation and viability curves of 32D/IRS1/Ras in the presence of G-CSF show that in these conditions the double transfectants survive and proliferate vigorously. Morphological analysis of cytospin preparations derived form cultures of dierent cell populations (Figure 3b) indicates that 32D/IRS1 cells behave as 32D/Ras cells in that they have lost the ability to dierentiate in the presence of G-CSF. 32D/IRS1/Ras cells are also incapable to undergo G-CSF-mediated granulocytic dierentiation (Figure 3b ). However, 32D/Shc cells undergo dierentiation in the presence of G-CSF, as observed for 32D parental cells ( Figure  3b ). The percentages of dierentiated cells in the presence of G-CSF are given in Table 1 . Notice that 32D/Shc cells, maintained in culture for extended periods of time (1 month after transfection, approximately), undergo spontaneous dierentiation in spite of the presence of IL-3 (Table 1) . Therefore, in 32D cells, ectopic expression of IRS-1 protein inhibits the dierentiation process but does not abrogate IL-3 dependence, whereas Shc over-expression promotes spontaneous granulocytic dierentiation. It is only the combined expression of IRS-1 and v-Ha-ras that inhibits dierentiation and abrogates IL-3 dependence. Cell numbers were determined in duplicate, at daily intervals, with a Thoma's hemocytometer. Cell viability was determined, at daily intervals, by trypan blue exclusion 
32D/IRS1/Ras cells are tumorigenic
Because 32D/IRS1/Ras grew vigorously without IL-3 and were refractory to dierentiation by G-CSF, we tested the double transfected cells for tumorigenicity. 2610 7 cells were injected subcutaneously into syngeneic C3H/HeJ and nu/nu mice and the animals were scored for tumor incidence and size. Table 2 shows that 32D/IRS1/Ras cells generate tumors in syngeneic and nu/nu mice, being somewhat more aggressive in nu/nu mice. As expected, control populations (32D/ IRS1 and 32D/Ras cells) were unable to form tumors, either in syngeneic or in nu/nu mice. Histological examination of sacri®ced mice indicated that tumorbearing mice showed large thymus, splenomegaly (4 ± 6-fold increase in weight, see Table 2 ), lymphadenopathy and tumors (Figure 4 ) in®ltrating the subcutaneous tissues. These results indicate that 32D/ IRS1/Ras cells generate tumors resembling human hematopoietic malignancies.
Activation of PI3-kinase in double transfectants
IRS-1 is known to be one of the most powerful activators of PI3-kinase (PI3-K) signaling (Myers et al., 1994; Peterson et al., 1996; Valentinis et al., 1999a) . We evaluated the levels of PI3-K activation in dierent transfected 32D cells. It has been previously reported that parental 32D cells do not show detectable levels of PI3-K activity (Soon et al., 1999) and that 32D cells expressing exogenous IRS-1 protein show a marked increase in AKT activation (Valentinis et al., 1999b; Peruzzi et al., 1999) . Accordingly, Figure 5 shows that in 32D parental cells the level of PI3-K activity is barely detectable, whereas it is evident in 32D/IRS1 cells. Interestingly, a similar level of activation is also detectable in 32D/ Ras cells, but the highest activity is evidenced in double transfectant 32D/IRS1/Ras cells. Thus, 32D-transformed cells display high levels of PI3-K activation.
Effect of PI3-K inhibitors
By using PI3-K inhibitors (LY294002 and wortmannin) we attempted to determine the role of PI3-K activation in the survival of 32D/IRS1/Ras transfectants. Dose response curves with both inhibitors were performed on dierent cell populations grown in standard culture conditions. One mM of wortmannin and 50 mM LY294002 were found optimal doses for all 32D transfectants (data not shown). Since identical results were achieved using LY294002 or wortmannin, we report only the data obtained with the use of LY294002. Proliferation and survival curves of 32D, 32D/IRS1 and 32D/Ras cells ( Figure 6 ) indicate that LY294002 treatment (a) inhibits growth signi®cantly, but does not aect the viability of non-transformed 32D cells. DNA content analysis con®rmed these ®ndings showing signi®cant accumulation of cells in the G1 phase of the cell cycle 24 h after addition of LY294002 (Figure 6b ). When similar experiments were performed on 32D/IRS1/Ras cells ( Figure 7 ) we observed that LY294002 treatment (a) abrogates both proliferation and viability of 32D-transformed cells. Furthermore, DNA content analysis con®rmed that, upon LY294002 treatment, 32D/IRS1/Ras cells exhibit a large hypodiploid peak indicative of cell death (Figure 7b ). These results indicate that PI3-K inhibitors induce cell death exclusively in 32D/IRS1/Ras cells, thus indicating that PI3-K activity is required for the survival of transformed cells.
Activation of MAP kinase cascade in double transfectants
Several reports in the literature have established IRS-1 as an activator not only of PI3-K (Avruch, 1998; Myers et al., 1993 Myers et al., , 1994 but also of the Ras signaling The dierentiation is calculated as the percentage of bands plus polymorphonuclear cells over living cells. *The determination of the extent of dierentiation was done at day 8. **The determination of the extent of dierentiation was done at days 36 ± 40 after Shc plasmid transfection pathways (Hugl et al., 1998; White, 1998) . To gain some information on signaling under these conditions, MAP kinase (MAPK) activation was studied in 32D non-transformed and transformed cell lines grown in the presence or absence of IL-3. Figure 8 shows that in the presence of IL-3, transformed cells (32D/IRS1/Ras) exhibit very high levels of ERK phosphorylation (P-ERK), whereas non-transformed cells (32D, 32D/IRS1, 32D/Ras) exhibit much lower levels of ERK phosphorylation. Even more dramatic are the dierences in the absence of IL-3. In these conditions, only 32D/IRS1/ Ras-transformed cells exhibit high levels of ERK phosphorylation. It is of some interest to note that in these transformed cells the levels of ERK phosphorylation (P-ERK-1, P-ERK-2) are not dependent on the presence of IL-3. By contrast, non-transformed 32D cells in the absence of IL-3 exhibit low levels of P-ERK-2 and barely detectable P-ERK-1. To elucidate possible dierences of ERK-1 and ERK-2 constitutive phosphorylation in 32D cells we determined MAPK activation in the absence of serum. Time course experiments as function of serum stimulation are reported in Figure 9 (a,b: 2 and 10 min of stimulation, respectively). The data of Figure 9 indicate that in 32D-transformed cells both ERK-1 and ERK-2 are constitutively phosphorylated independently of growth factor supply (serum and/or IL-3) and, as expected, serum increases signi®cantly ERK-1 and ERK-2 phosphorylation. Under the same experimental conditions, ERK-1 and ERK-2 phosphorylation is undetectable in non-transformed, unstimulated cell lines (32D, 32D/IRS1, 32D/Ras). After 10 min of serum stimulation these cell lines (Figure 9b ) express signi®cant increase in P-ERK-1 and P-ERK-2 in good agreement with data previously reported (Valentinis et al., 1999a) . These data indicate that both ERK-1 and ERK-2 are constitutively phosphorylated in 32D cells upon concomitant expression of IRS-1 and oncogenic Ras independently of growth factor supply (serum and/or IL-3). MAPK activity was assayed on dierent cell lines growing in standard conditions (+FCS) or maintained in the absence of serum (w/o FCS) and IL-3 for 2 h (Figure 9c ). Kinase assays con®rmed that 32D-transformed cells show the highest MAPK activity, being constitutively active in the absence of serum and IL-3. Altogether these data indicate that 32D transformation correlates with constitutive MAPK activation and that IRS-1 and Ras signals converge on MAPK generating a high level of activation. 
Effects of MEK inhibitor
To test whether the activation of MAPK is critical for the survival of 32D/IRS1/Ras transfectants, we treated these transformed cells with an inhibitor of MEK (PD98059). As a control, two dierent inhibitors (SB203580 and SB202190) of p38 MAPK (Engelman et al., 1998) were also employed. Dose-response curves with both inhibitors were performed on dierent cell populations grown in standard culture conditions. Fifty mM of PD98059 (Dews et al., 2000) and 10 mM of SB203580 or SB202190, respectively, were found optimal doses for all 32D transfectants (data not shown). Proliferation and survival curves of 32D, 32D/ IRS1 and 32D/Ras (Figure 10 ) indicate that PD98059 treatment (a) partially inhibits the growth but does not aect the viability of 32D non-transformed cells. DNA content analysis con®rmed these ®ndings showing Figure 8 Western blot analysis of MAPK in 32D-derivative cell lines in the presence of IL-3 or 6 h after IL-3 withdrawal. 2.5610 6 cells growing in medium containing 10% FCS and IL-3 were centrifuged, washed in PBS and grown for an additional period of time (6 h) in the presence or absence of IL-3. The rabbit polyclonal anti-active MAPK antibody recognizes ERK phosphorylated proteins (P-ERK-1 and P-ERK-2), whereas the rabbit polyclonal K23 antibody recognizes all forms of ERK proteins (ERK-1 and ERK-2). Protein levels (ERK-1 and ERK-2) were determined on the same blots after membrane stripping. Ponceau S staining of the blot con®rmed equal protein loading cells growing in medium containing 10% FCS and IL-3 were centrifuged, washed in cold PBS and grown for additional 2 h in the absence of both FCS and IL-3. Thereafter, dierent cell samples were stimulated for 2 min or 10 min with 10% FCS. (a) 2 min after FCS addition. (b) 10 min after FCS addition. The rabbit polyclonal antibody anti-active MAPK recognizes ERK phosphorylated proteins (P-ERK-1 and P-ERK-2), whereas the rabbit polyclonal K23 antibody recognizes all forms of ERK proteins (ERK-1 and ERK-2). Protein levels (ERK-1 and ERK-2) were determined on the same blots after membrane stripping. Ponceau S staining of the blot con®rmed equal protein loading. (c) MAP kinase assay in 32D-derivative cell lines. Samples of 2610 7 cells growing in medium containing 10% FCS and IL-3 were centrifuged, washed in PBS and directly lysed (+FCS), or grown for additional period of time (2 h) in the absence of FCS and IL-3 (w/o FCS) and, then, lysed. Equal amounts (1 mg) of total protein from dierent lysates were immunoprecipitated with K23 antibody and immune complexes assayed for kinase activity on myelin basic protein (MBP) substrate. The phosphorylated substrate (MBP) from dierent samples was analysed by SDS ± PAGE. To determine the protein levels (ERK-1 and ERK-2) the same lysates were analysed by Western blot using the rabbit polyclonal K23 antibody slight but signi®cant increase of the cells in the G1 phase of the cell cycle 24 h after drug addition ( Figure  10b ). On the contrary, p38 MAPK inhibitors (SB203580 and SB202190) neither inhibit the growth nor aect the viability of 32D non-transformed cells (data not shown). When similar experiments were performed on 32D/IRS1/Ras cells (Figure 11 ) we observed that PD98059 treatment (a) concomitantly abrogates proliferation and viability of these 32D-transformed cells. Furthermore, DNA content analysis con®rmed that, upon PD98059 treatment, 32D/IRS1/ Ras cells exhibit a large hypodiploid peak indicative of cell death (Figure 11b ). The speci®city of the eects generated by MEK inhibitor on 32D/IRS1/Ras cells was con®rmed when p38 MAPK inhibitors were employed. Indeed, these inhibitors neither aect proliferation or viability of 32D-transformed cells as also con®rmed by DNA content analyses (b). These results indicate that PD98059 induces cell death only in 32D-transformed cells, whereas inhibitors of p38 MAPK activity have no eects. These results are in good agreement with data reported in Figures 8 and 9 and con®rm the relevance of ERK phosphorylation in 32D-cell transformation upon concomitant expression of IRS-1 and oncogenic Ras. Overall, the data reported indicates that MAPK and PI3-K activity are required for the survival of transformed cells.
Discussion
The main ®ndings of these experiments with 32D cells are the following: (1) the expression of IRS-1 or Ras, singly, inhibits their dierentiation potential (by G-CSF), but does not abrogate their IL-3 requirement.
(2) In contrast, the combined ectopic expression of IRS-1 and Ras abrogates IL-3 dependence, and these cells (32D/IRS1/Ras cells) can form tumors in both syngeneic and nude mice. (3) In the transformed cell line, there is a constitutive activation of both PI3-K and MAPK, two pathways that are intimately involved in both IRS-1 and Ras signaling. (4) As a logical corollary, inhibitors of either PI3-K or MAPK activities block transformation. However, these inhibitors, singly, not only block transformation, but actually cause massive cell death. The same inhibitors only cause growth arrest in the non-transformed cell lines. These ®ndings will be discussed separately.
It has been postulated that myelodysplasia show block of dierentiation, and progress to acute leukemia when additional events provide autonomous growth stimulation (Sawyers et al., 1991) . Since the IGF-1R is known to play an important role in malignant transformation , we asked whether 32D/Ras cells, a cognate myelodyplastic syndrome, become leukemic upon re-activation of the IGF-1R signaling pathway. 32D cells have low levels of IGF-1R, do not have IRS-1 and express high levels of two Shc proteins (see Introduction). We therefore studied the eect of IRS-1 introduction and increased Shc expression in 32D/Ras cells. We report that IRS-1 de novo expression but not Shc over-expression allows leukemic conversion of 32D cells expressing oncogenic Ras (32D/Ras cells). The transformation of 32D cells expressing both IRS-1 and v-Ha-Ras (32D/IRS1/Ras cells) is documented by three ®ndings: (1) they proliferate and survive in the absence of IL-3, (2) they fail to undergo G-CSF-induced dierentiation, and (3) they form tumors in syngeneic and nu/nu mice. In contrast, double transfection of v-Ha-Ras and Shc (32D/Shc/Ras cells) does not transform 32D cells. IRS-1 by itself is incapable of transforming 32D cells and to protect them from apoptosis induced by IL-3 withdrawal (Peruzzi et al., 1999) . However, IRS-1 inhibits G-CSF-dependent dierentiation of 32D cells. Thus, in 32D cells either ectopically expressed IRS-1 or oncogenic Ras generate a similar myelodisplastic phenotype. These ®ndings allow speculation that two dierentiation blocks, originating from dierent signals (IRS-1 and v-Ha-Ras), result in transformation of 32D cells. In addition, since transformation of 32D cells occurs independently whether IRS-1 expression is generated before or after v-Ha-Ras expression, it appears that transformation strictly depends upon the sum of the two events (IRS-1 plus v-Ha-Ras) and not upon their order of activation. The contribution of IRS-1 to the transformation of 32D cells is determinant. Mere higher expression of Ras protein does not transform 32D cells. We have previously reported that v-HaRas regardless of its expression levels does not transform 32D cells (Soddu et al., 1996b) . Moreover, unpublished data from our laboratories indicate that, nevertheless IGF-1R signaling stabilizes the Ras oncoprotein, in 32D cells the over-expression of IGF-1R by itself does not generate IL-3-independence and/or transformation. By contrast, IRS-1 contributes with the IGF-1R to the transformation of 32D cells (Valentinis et al., 1999b) .
Leukemic conversion of 32D/Ras cells upon IRS-1 de novo expression may be explained assuming that two pathways are required for transformation: one provided by v-Ha-Ras and the other by IRS-1. Alternatively, it may be postulated that transformation occurs because IRS-1 co-operates with v-Ha-Ras in activating the same pathway/s. The observation that 32D/IRS1/Ras-transformed cells, but not their nontransformed counterparts (32D, 32D/IRS1, 32D/Ras), die when incubated with PI3-K inhibitors suggests that PI3-K activation is an absolute requirement for 32D cell transformation and survival. In addition, kinase assays indicate that 32D-transformed cells have a markedly increased level of PI3-K activation, signi®-cantly higher than in 32D/IRS1 or 32D/Ras nontransformed counterparts. Since IRS-1 is one of the strongest activators of PI3-K (Hugl et al., 1998) , these results con®rm the need of IRS-1 for 32D/Ras cell transformation.
In the literature there is substantial evidence that IRS-1 activates the PI3-K pathway leading to Akt/ PKB phosphorylation (Kulik et al., 1997; Kulik and Weber, 1998) . Thus, one of the pathways activated by the combination of IRS-1 and Ras could be the PI3-K pathway, presumably through IRS-1, although there are reports in the literature showing that also Ras can activate PI3-K (Khwaja et al., 1997) . Our data show that 32D-cell transformation, in addition to PI3-K activity, requires MAPK activation. We report that IRS-1 and v-Ha-Ras co-operate in generating a strong and constitutive activation of MAPK in good agreement with the notion that IRS-1 activates the Ras pathway by binding to Grb2 (Hugl et al., 1998; White, 1998) . Indeed, we observe that only 32D/IRS1/Rastransformed cells exhibit constitutive phosphorylation of ERK-1 and ERK-2 independently of growth factor supply (IL-3 and/or serum). Furthermore, the relevance of ERK activation in 32D-cell transformation is clearly demonstrated. MEK inhibitor kills 32D-derivative transformed cells but not its non-transformed counterparts. It indicates that the activation of a single pathway (PI3-K or ERK) by itself is not sucient for 32D-cell transformation. In fact, 32D/IRS1/Rastransformed cells die when speci®c (PI3-K or MEK) inhibitors abolish either one of the two pathways, but survive and proliferate when unspeci®c inhibitors are employed (p38 MAPK inhibitors). Against the hypothesis that a single pathway, the ERK pathway, may be sucient for transformation is also the observation that Shc over-expression does not allow transformation of 32D cells expressing v-Ha-Ras. Shc proteins are known to signal through the Ras pathway (Myers et al., 1994; White, 1998) . Nevertheless, we cannot exclude that IRS-1 and v-Ha-Ras may also activate other pathways.
Altogether our results indicate that: (i) the expression of IRS-1 or v-Ha-Ras, singly, does not provide adequate activation of dierent signaling pathways for malignant transformation, and (ii) 32D-cell transformation requires the co-operation of IRS-1 and v-HaRas at least through two pathways (PI3-K and MAPK). Indeed, inhibition of either pathway leads to cell death only in 32D/IRS1/Ras cells, as if the activation of one pathway only causes unbalanced cell growth and, therefore, cell death. Finally, the fact that 32D cell transformation requires enhanced signaling of at least two pathways, supports the hypothesis that leukemic conversion occurs when adequate activation of multiple signaling pathways is attained, independently of whether it is achieved through one (v-src, or v-abl) (Chaturvedi et al., 1997) or two hits (v-Ha-Ras and IRS-1).
Materials and methods
Cell lines
32Dc13 (32D) murine myeloid precursor cells, and derivative cell lines 32D/Ras and 32D/Shc were maintained in RPMI 1640 medium (GIBCO-BRL, Life Technology, Grand Island, NY, USA) supplemented with 10% heat-inactivated fetal calf serum (FCS; Biological Industries, Kibbuz Beit Haemek, Israel) and 5% conditioned medium from the murine myelomonocytic cell line WEHI-3B as source of crude IL-3. 32D/IRS1 cells were cultured in RPMI 1640 with 10% FCS and 10% IL-3. 32D/IRS1/Ras and 32D/Shc/Ras were maintained in RPMI 1640 with 10% FCS, without IL-3. WEHI-3B cells were cultured in RPMI 1640 medium with 10% of FCS.
Plasmids and viruses
The following plasmids were used for transfections: pcDNA3-Shc, carrying the wild type Shc cDNA under the control of CMV promoter and the selectable marker for neomycin resistance. The plasmid carrying wild type IRS-1 cDNA has been described elsewhere (Araki et al., 1993) . The following retroviral vectors were used for infections: Ras-zip recombinant ecotropic retrovirus, coding for the v-Ha-Ras oncogene and neomycin resistance gene, was produced in C-2 packaging cells. Replication-competent v-Ha-Ras-expressing murine sarcoma virus (MSV) was obtained from the supernatant of MSV-infected NIH-3T3 cells (NIH3T3/Ha-MSV).
Transfections and infections
Exponentially growing cells ( 5610 6 ) were transfected by electroporation (0.2 kV, 950 mF), using a Gene Pulser (BioRad Laboratories, Inc., Hercules, CA, USA). Packaging cells ( 1610 6 ) were treated for 2 h with mitomycin (10 mg/ml) to inhibit cell replication. Twenty-four hours after mitomycin removal, 1610 6 cells, treated for 1 h with Polybrene (8 mg/ ml), were infected by in vitro co-cultivation with the packaging cells. Twenty-four hours after co-cultivation, the infected cells were removed from the packaging monolayer and re-plated in fresh medium. After a further 24 h, Ras-zip infected cells were selected in G418 containing medium (1.5 mg/ml) for 7 days to eliminate the uninfected cells. Approximately 1610 6 cells, treated for 1 h with Polybrene (8 mg/ml), were incubated for 48 h with the supernatant of NIH3T3/Ha-MSV cells. Forty-eight hours after, the infected cells were washed and re-plated in fresh medium. The infected populations were, then, grown in the absence of IL-3 to selected IL-3 independent cells. Selected mixed populations were assayed for their tumorigenicity in nude and syngeneic mice.
Growth and viability curves
Exponentially growing cells were plated in RPMI 1640 with 10% FCS in the presence or absence of IL-3. Typically, 2610 5 cells (5610 4 cells/ml) were plated in medium containing 10% FCS (see above) in the presence or absence of 5% conditioned medium for IL-3 supply as de®ned in Figure  legends . Cell numbers were determined in duplicate, at daily intervals, with a Thoma's hemocytometer. Viability cell number was determined by trypan blue exclusion.
Granulocytic differentiation analysis
Exponentially growing (2610 5 ) 32D and derivative cells were plated in RPMI 1640 medium supplemented with 10% FCS and 20% conditioned medium from the murine glioblastoma cell line U87-MG as source of crude G-CSF. After 4, 8 and 12 days, approximately 4610 4 cells were spun onto glass slide by cytocentrifugation (400 r.p.m. for 5 min). For morphological analysis, cytospin preparations were ®xed and stained by May-Grunwald-Giemsa (Sigma, St Louis MO, USA) and observed under a light microscope. Bands and polymorphonuclear cells were scored for dierentiated cells.
Tumor analysis
Exponentially growing cells (2.5610 7 ) cells were injected s.c. (between the scapulae) in syngeneic C3H/HeJ (from 6 ± 7-week-old males) and nu/nu mice. Mice were examined twice a week for the appearance of tumor masses. Sick animals were sacri®ced. Autopsy and macroscopic examination of organs were performed on sacri®ced mice.
Kinase assays
To assay PI3-K activity the exponentially growing cells were washed and lysed in 10 mM HEPES pH 7.5, 0.15 M NaCl, 10% glycerol in the presence of protease and phosphatase inhibitors. Nuclei were removed by centrifugation at 12 000 g for 15 min at 48C. After lysis, aliquots of cell extracts containing equivalent amounts of protein were incubated overnight at 48C with anti-P-tyr mAb 4G10 (UBI, Lake Placid, NY, USA) and protein G (PIERCE, Rockford, IL, USA). The beads were washed twice with lysis buer (10 mM HEPES pH 7.5, 0.15 M NaCl, 10% glycerol, and 1% NP-40); twice with 0.5 M LiCl; twice with 10 mM HEPES pH 7.5, 0.15 M NaCl and 0.2% NP-40; and once with 10 mM HEPES pH 7.5, 0.15 M NaCl. After removal of the last wash, the beads were suspended in 30 ml of 30 mM HEPES pH 7.5 and 30 ml of kinase buer containing 10 mg (20 ml) of L-a-Phosphatidylinositol from bovine liver (Sigma) sonicated in 10 mM HEPES and 1 mM EDTA, 80 mM ATP (Roche, Molecular Biochemicals), 20 mCi of [g 32 P]ATP (6.000 Ci/mMol), 10 mM MgCl 2 and 400 mM Adenosine (Sigma), and incubated for 25 min at room temperature. The reaction was stopped by the addition of 100 ml 1 M HCl and 200 ml of 1 : 1 mixture of Chloroform and Methanol were added. The organic phase was then washed twice with 300 ml of 1 : 1 mixture of Methanol and HCl. The lipid extracts (20 ml of each reaction) were then resolved by thin layer chromatography plates (TLC Silica gel) (MERK, Darmstad, Germany) in cloroform, Methanol and Ammonium Hydroxide. Dried TLC sheets were developed by autoradiography.
To assay MAPK activity 2610 7 exponentially growing cells, or identical amounts of cells maintained for 2 h without FCS and IL-3, were lysed in 500 ml of lysis buer (0.2% Triton-X-100, 50 mM Tris HCl pH 7.5, 5 mM EDTA) in the presence of protease and phosphatase inhibitors. Lysates were sonicated and centrifuged at 14 000 r.p.m. for 30 min at 48C. Aliquots of cell extracts containing equivalent amounts of total protein (1 mg) were immunoprecipitated for 2 h at 48C with 10 ml of K23 antibody (Santa Cruz) adsorbed to protein G-Sepharose beads (KPL, MD, USA). Immune complexes collected by centrifugation were washed three times with lysis buer and twice with kinase buer (20 mM HEPES pH 7.4, 10 mM MgCl 2 , 1 mM DTT, 200 mM Na 3 VO 4 ). MAPK activity was assayed on ®nal pellets suspended in 30 ml of kinase buer, supplemented with 3 mCi of [g-32 P]ATP, 50 mM of cold ATP and 20 mg of myelin basic protein (MBP) (GIBCO), and incubated for 15 min at 308C. Kinase assays were stopped by adding Laemmli's buer and heating the samples for 5 min at 958C. The phosphorylated substrate (MBP) was resolved by SDS ± PAGE onto 15% polyacrilamide gel.
PI3-K inhibition analysis
Cells (5610 5 cells/ml) were incubated with or without wortmannin (1 mM) or LY294002 (50 mM) (Biomol Research Laboratories, Inc., Plymouth Meeting, PA, USA) for 12, 16, 24, 40 and 70 h. After the indicated period of times, 5610 5 cells were ®xed for 30 min at 48C in methanol/acetone (1 : 4) cold solution. The DNA was stained for 30 min at room temperature with propidium iodide (50 mg/ml) (Sigma) and dissolved in PBS containing 1 mg/ml of RNAse A (Roche, Molecular Biochemicals). The DNA content was evaluated by an Epics XL analyzer (Coulter Corporation, Miami, FL, USA).
